Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierBiologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases
dc.contributor.authorMOHAMMEDI, Kamel
dc.contributor.authorHARRAP, Stephen
dc.contributor.authorMANCIA, Giuseppe
dc.contributor.authorMARRE, Michel
dc.contributor.authorPOULTER, Neil
dc.contributor.authorCHALMERS, John
dc.contributor.authorWOODWARD, Mark
dc.date.accessioned2021-02-02T16:23:29Z
dc.date.available2021-02-02T16:23:29Z
dc.date.issued2021-01-04
dc.identifier.issn1475-2840en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/26107
dc.description.abstractEnIndividuals with diabetes and lower-limb complications are at high risk for cardiovascular and all-cause mortality, but uncertainties remain in terms of cancer-related death in this population. We investigated this relationship in a large cohort of people with type 2 diabetes. We used data from the Action in Diabetes and Vascular Disease: PreterAx and DiamicroN Modified-Release Controlled Evaluation (ADVANCE) study. The primary outcome was adjudicated cancer death; secondary outcomes were overall and site-specific incident cancers, determined according to the International Classification of Diseases Code (ICD-10). We compared outcomes in individuals with (versus without) a baseline history of lower-limb complications (peripheral artery disease (PAD) or sensory peripheral neuropathy) using Cox regression models. Among 11,140 participants (women 42%, mean age 66 years), lower-limb complications were reported at baseline in 4293 (38%) individuals: 2439 (22%) with PAD and 2973 (27%) with peripheral neuropathy. Cancer death occurred in 316 (2.8%) participants during a median of 5.0 (25th-75th percentile, 4.7-5.1) years of follow-up corresponding to 53,550 person-years and an incidence rate of 5.9 (95% CI 5.3-6.6) per 1000 person-years. The risk of cancer death was higher in individuals with (versus without) lower-limb complication [hazard ratio 1.53 (95% CI, 1.21-1.94), p = 0.0004], PAD [1.32 (1.02-1.70), p = 0.03] or neuropathy (1.41 (1.11-1.79), p = 0.004], adjusting for potential confounders and study allocations. PAD, but not neuropathy, was associated with excess risk of incident cancers. PAD and peripheral neuropathy were independently associated with increased 5-year risk of cancer death in individuals with type 2 diabetes. PAD was also associated with increased risk of incident cancers. Our findings provide new evidence on the non-cardiovascular prognostic burden of lower-limb complications in people with type 2 diabetes.
dc.language.isoENen_US
dc.rightsAttribution 3.0 France (CC BY 3.0 FR)
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/fr/
dc.subjectarticle clinique
dc.title.enHistory of lower-limb complications and risk of cancer death in people with type 2 diabetes.
dc.title.alternativeCardiovasc Diabetolen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1186/s12933-020-01198-y
dc.subject.halSciences du Vivant [q-bio]/Médecine humaine et pathologie
dc.identifier.pubmed33397352en_US
bordeaux.journalCardiovascular Diabetologyen_US
bordeaux.page3en_US
bordeaux.volume20en_US
bordeaux.hal.laboratoriesBiologie des maladies cardiovasculaires - U1034en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcepubmed
hal.identifierhal-03159232
hal.version1
hal.date.transferred2021-03-04T12:56:45Z
hal.update-error.statusmetadataUpdate
hal.exportfalse
workflow.import.sourcepubmed
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Cardiovascular%20Diabetology&rft.date=2021-01-04&rft.volume=20&rft.issue=1&rft.spage=3&rft.epage=3&rft.eissn=1475-2840&rft.issn=1475-2840&rft.au=MOHAMMEDI,%20Kamel&HARRAP,%20Stephen&MANCIA,%20Giuseppe&MARRE,%20Michel&POULTER,%20Neil&rft.genre=article


Fichier(s) constituant ce document

Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée